Legal Representation
Attorney
Daniel M. Gurfinkel
USPTO Deadlines
Next Deadline
In Grace Period
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20190813)
Due Date
August 13, 2025
Grace Period Ends
February 13, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 17, 2025 | NA75 | E | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | Loading... |
| Dec 17, 2025 | C75A | O | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | Loading... |
| Dec 15, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Aug 13, 2025 | ES75 | I | TEAS SECTION 71 & 15 RECEIVED | Loading... |
| Jul 24, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 24, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 24, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 24, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jul 24, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Apr 16, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 16, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Apr 16, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Apr 16, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Apr 16, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Apr 11, 2025 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| Aug 13, 2024 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | Loading... |
| Apr 2, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Jan 29, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Oct 22, 2021 | INNA | R | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | Loading... |
| Sep 26, 2021 | INPR | P | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | Loading... |
| Apr 23, 2021 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| Jan 29, 2021 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | Loading... |
| Jan 26, 2021 | COC. | O | CORRECTION UNDER SECTION 7 - PROCESSED | Loading... |
| Jan 26, 2021 | PLGL | A | ASSIGNED TO PARALEGAL | Loading... |
| Oct 31, 2020 | LIMN | I | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | Loading... |
| Oct 24, 2020 | FINP | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Aug 7, 2020 | CORN | I | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | Loading... |
| Jul 3, 2020 | CRCV | M | CORRECTION TRANSACTION RECEIVED FROM IB | Loading... |
| Jul 3, 2020 | LIMG | M | LIMITATION OF GOODS RECEIVED FROM IB | Loading... |
| Jun 24, 2020 | XXSS | O | GENERIC MADRID TRANSACTION SENT TO IB | Loading... |
| Mar 5, 2020 | IRRH | M | IRREGULARITY FROM IB EXAMINED BY MPU | Loading... |
| Jan 23, 2020 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Jan 16, 2020 | IRFI | M | IRREGULARITY ON FINAL DECISION RECEIVED FROM IB | Loading... |
| Dec 6, 2019 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Dec 6, 2019 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Nov 13, 2019 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Aug 13, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 28, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 28, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 8, 2019 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| May 8, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 8, 2019 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Apr 24, 2019 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Apr 24, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 24, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 24, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 24, 2019 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 24, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 19, 2019 | CRTP | C | REG. CANCELLED - RESTORED TO PENDENCY | Loading... |
| Mar 18, 2019 | RCII | I | REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED | Loading... |
Detailed Classifications
Class 001
Chemicals for the manufacture of pharmaceutical products; chemical additives used in the manufacture of pharmaceutical preparations; albumin used in industry for the preparation of pharmaceutical compositions, reagents, and diagnostic reagents
Class 005
Pharmaceutical compositions and substances for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; diagnostic reagents for pharmaceutical medicinal use; diagnostic reagents for medical use; protein supplements for pharmaceutical and medical purposes; albuminous preparations for pharmaceutical and medical purposes; recombinant human albumin sold as an integral component of a vaccine and pharmaceuticals for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; diagnostic agents for medical imaging [ ; pharmaceutical products and preparations for supporting drugs by reducing the time it takes for the body to break down the active pharmaceutical ingredient ]
Class 042
Research and development services relating to pharmaceutical products
Additional Information
Other
In the Statement, class 5 has been corrected per the Restriction dated January 17, 2019, and the Fnote dated January 26, 2019.
Other
In the Statement, class 5 has been corrected per the Restriction and the Fnote dated January 22, 2021.
Classification
International Classes
001
005
042